
Revaly helps subscription and recurring-revenue businesses stop losing money to failed transactions by transforming payment systems into revenue engines. Its AI-driven payment intelligence evaluates issuer signals and network behavior in real time to keep legitimate payments from failing. Instead of letting small errors or timing issues derail a customer’s purchase, Revaly corrects problems proactively before the user hits “pay.” When a payment does decline, the platform automatically determines the best moment and method to retry, using behavioral science to protect customer trust. Companies using Revaly see major increases in recovered revenue, improved profitability, and significantly reduced involuntary churn. The platform integrates with more than 100 billing, CRM, and payment tools, eliminating the need for operational changes. Performance metrics across retail, software, and media industries consistently show double-digit recovery improvements. Ultimately, Revaly gives businesses a predictable, scalable way to grow by ensuring their earned revenue successfully processes.
Learn more

The sovereign AI that turns every answer into lasting expertise.
Cut response times by up to 90%. Optivalue.ai automates information discovery and drafting, freeing experts for the high-impact personalization that wins bids. It acts as an expert librarian for your knowledge base: submit a questionnaire — RFP, audit, security or compliance — and get a complete, source-verified draft in minutes.
Every answer is built on 89 Domain-Specific Language Models specialized by function and industry, not a generic LLM. Each answer carries a 0-100 confidence score and precise source citations (document, page, timestamp) for full traceability. When no source supports an answer, Optivalue.ai says "I don't know" rather than hallucinate. You don't just answer correctly — you prove it.
It's an engine of progress for your organization. Optivalue.ai runs a gap analysis to identify weaknesses in your documentation. Following the recommendations strengthens your internal documents and builds lasting expertise across the organization.
Your data stays yours: a private AI per client, never shared, deployed on-premise or in a sovereign cloud. Enterprise-grade security, compliant with GDPR, ISO 27001, HIPAA, SOC 2 and FedRAMP. All plans include unlimited users and unlimited projects. Start your 14-day free trial — no credit card, no commitment.
Trusted by L'Oréal, Stellantis, Thales Alenia Space, Exaion (EDF Group), Equans and Mango. Winner of the European Sovereignty Prize 2026 (AI category).
Learn more
VeraChem
Founded in 2000, VeraChem LLC aims to enhance the field of computer-aided drug discovery and molecular design by creating advanced computational chemistry techniques that merge innovative basic science with practical applications in research. A key aspect of the company's strategy for product development lies in delivering efficient, high-performance software solutions along with extensive user support. Among the current capabilities of VeraChem's software are predictions for protein-ligand and host-guest binding affinities, rapid and precise calculations of partial atomic charges for drug-like molecules, and the computation of energies and forces utilizing widely-used empirical force fields. Additionally, the software features automatic generation of alternate resonance forms for drug-like compounds, a robust conformational search enabled by the Tork algorithm, and the automatic identification of topological and three-dimensional molecular symmetries. The modular code base of VeraChem’s software packages allows for flexibility and adaptability in meeting diverse research needs, ensuring that users can leverage these tools effectively for their specific applications.
Learn more
Iktos
Makya stands out as the pioneering user-centric SaaS platform dedicated to AI-enhanced de novo drug design, particularly emphasizing Multi-Parametric Optimization (MPO). This innovative tool empowers users to create novel and easily synthesize compounds based on a multi-objective framework, achieving unprecedented levels of speed, efficiency, and variety. Makya incorporates a range of generative algorithms tailored to various stages of drug development, from hit discovery to lead optimization; it includes a fine-tuning generator for pinpointing ideal solutions within your specified chemical landscape, a novelty generator designed to explore fresh concepts for re-scaffolding and hit discovery, and a forward generator to create a targeted library of compounds that can be readily synthesized from commercially available starting materials. The recently introduced Makya 3D module significantly improves both the user interface and the scientific capabilities of the platform. With a comprehensive array of 3D modeling functionalities available for both ligand-based and structure-based approaches, Makya 3D allows for the calculation of 3D scores, which can be seamlessly utilized to guide compound generation within the platform. This integration not only enhances the design process but also offers researchers deeper insights into their molecular designs.
Learn more